Clinical and treatment characteristic | Median (range)/n (%) |
---|---|
Age | 61 (26–93) |
Sex | |
Male | 89 (88%) |
Female | 12 (12%) |
Smoking history | |
No | 29 (29%) |
Active smoking | 25 (25%) |
Quit smoking < 10 years | 33 (33%) |
Quit smoking ≥ 10 years | 14 (13%) |
Stage | |
1 | 4 (4%) |
2 | 3 (3%) |
3 | 71 (70%) |
4 | 23 (23%) |
Treatment setting | |
CCRT | 95 (94%) |
RT | 6 (6%) |
RT aim | |
Preoperative | 47 (47%) |
Postoperative (adjuvant) | 1 (1%) |
Definitive | 49 (48%) |
Palliative | 4 (4%) |
Prescription dose | 50.4 (30.0–60.0) |
Prescription dose per fraction | 1.8 (1.8–3.0) |
RT modality | |
3D conformal RT | 78 (77%) |
IMRT/VMAT | 9 (9%) |
Combine | 14 (14%) |
RP grade | |
0 | 38 (38%) |
1 | 58 (57%) |
2 | 5 (5%) |
3 | 0 (0%) |
4 | 0 (0%) |